APA

Oppegard L. M., Delgado J. L., Kulkarni C. A., Towle T. R., Hart D. E., Williams B. P., Lentz S. R. C., Norris B. J., Flory C. M., Schumacher R. J., Murry D. J., Kerns R. J. & Hiasa H. (20200205). Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. : Investigational new drugs.

Chicago

Oppegard Lisa M, Delgado Justine L, Kulkarni Chaitanya A, Towle Tyrell R, Hart Delaney E, Williams Bridget P, Lentz Sarah R C, Norris Beverly J, Flory Craig M, Schumacher Robert J, Murry Daryl J, Kerns Robert J and Hiasa Hiroshi. 20200205. Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. : Investigational new drugs.

Harvard

Oppegard L. M., Delgado J. L., Kulkarni C. A., Towle T. R., Hart D. E., Williams B. P., Lentz S. R. C., Norris B. J., Flory C. M., Schumacher R. J., Murry D. J., Kerns R. J. and Hiasa H. (20200205). Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. : Investigational new drugs.

MLA

Oppegard Lisa M, Delgado Justine L, Kulkarni Chaitanya A, Towle Tyrell R, Hart Delaney E, Williams Bridget P, Lentz Sarah R C, Norris Beverly J, Flory Craig M, Schumacher Robert J, Murry Daryl J, Kerns Robert J and Hiasa Hiroshi. Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. : Investigational new drugs. 20200205.